TO ASSESS THE IMPACT OF VITAMIN D SUPPLEMENTATION ON PROTEINURIA IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS, CONSIDERING THE AVERAGE ALTERATION IN THE URINARY ALBUMIN/CREATININE RATIO (UACR)
Main Article Content
Keywords
Vitamin D, Type 2 Diabetes Mellitus, proteinuria, urinary albumin-to-creatinine ratio, diabetic nephropathy, supplementation.
Abstract
Introduction: Vitamin D is normally low in T2DM patients and low levels make the damage of diabetic kidneys worse. Blood tests formerly known as UACR help to determine levels of proteins in urine to identify kidney damage at its early stages in patients with T2DM.
Objectives: The present study was designed to measure the efficacy of vitamin D supplementation in modifying proteinuria in T2DM patients through the evaluation of UACR after 6 months.
Materials and Methods: A group of investigators conducted a trial with 150 patients afflicted by both type-2 diabetes and high urinary albumin excretion by forming groups. The study divided the subjects into two equal groups and administered 1000 IU of vitamin D daily supplements to the first group while the second group was given a placebo for six months.
Results: The vitamin D intervention was also found to have achieved better outcome in the lowering of UACR than the placebo group and improved the serum levels of vitamin D.
Conclusion: Vitamin D helps reduce protein loss from the kidneys of type 2 diabetes patients to stop the progression of kidney damage.
References
2. Mahemuti, N., Zou, J., Liu, C., Xiao, Z., Liang, F. and Yang, X., 2023. Urinary albumin-to-creatinine ratio in normal range, Cardiovascular Health, and all-cause mortality. JAMA Network Open, 6(12), pp.e2348333-e2348333.
3. Zhuang, N.N. and You, H.J., 2024. Role of vitamin D3 in lipid metabolism and chronic pain in advanced diabetic kidney disease and its rehabilitation. Healthcare and Rehabilitation, 1(1), p.100005.
4. Sun, Y., Jin, D., Zhang, Z., Zhang, Y., Zhang, Y., Kang, X., Jiang, L., Tong, X. and Lian, F., 2023. Effects of antioxidants on diabetic kidney diseases: mechanistic interpretations and clinical assessment. Chinese Medicine, 18(1), p.3.
5. Gameil, M.A., Marzouk, R.E., El-Sebaie, A.H. and Ahmed Eldeeb, A.A., 2023. Influence of time factor and albuminuria on characteristics of patients with type 2 diabetes Mellitus before, during and 1 year after COVID-19 recovery. Diabetology & Metabolic Syndrome, 15(1), p.126.
6. Dean, Y.E., Elawady, S.S., Shi, W., Salem, A.A., Chotwatanapong, A., Ashraf, H., Reddi, T., Dundi, P.O.R., Habash, W.Y., Habash, M.Y. and Ahmed, S., 2023. Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients. Endocrinology, Diabetes & Metabolism, 6(6), p.e453.
7. Zhang, X., Zhang, L., Wen, Y., Zhang, M., Liu, S. and Xiao, H., 2023. Vitamin D ameliorates podocyte injury by enhancing autophagy activity in diabetic kidney disease. Kidney and Blood Pressure Research, 48(1), pp.314-325.
8. Elbarbary, N.S., Ismail, E.A.R. and Mohamed, S.A., 2023. Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial. Clinical Nutrition, 42(12), pp.2372-2380.
9. Kamel, A.A., Elnaggar, M.G., Hamad, D.A., Zakhary, M.M. and Bakkar, S.M., 2022. The Role of Vitamin D, DKK1, Hepcidin and Oxidative Stress Biomarkers in Type 2 Diabetes Mellitus Patients With and Without Diabetic Nephropathy. The Egyptian Journal of Hospital Medicine, 89(2), pp.7137-7146.
10. He, X., Sun, J., Liu, C., Yu, X., Li, H., Zhang, W., Li, Y., Geng, Y. and Wang, Z., 2022. Compositional alterations of gut microbiota in patients with diabetic kidney disease and type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, pp.755-765.
11. ElSayed, N.A., Aleppo, G., Aroda, V.R., Bannuru, R.R., Brown, F.M., Bruemmer, D., Collins, B.S., Hilliard, M.E., Isaacs, D., Johnson, E.L. and Kahan, S., 2023. 11. Chronic kidney disease and risk management: standards of care in diabetes—2023. Diabetes Care, 46(Supplement_1), pp.S191-S202.
12. Zanchi, A., Jehle, A.W., Lamine, F., Vogt, B., Czerlau, C., Bilz, S., Seeger, H. and de Seigneux, S., 2023. Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology. Swiss medical weekly, 153(40004), p.40004.
13. shamim Khan, A., Zubair, M., Khan, S., Sultan, K. and Khan, M.K., 2022. The role of vitamin D deficiency and supplementation in onset and progression of diabetic nephropathy: A systematic review. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 29(1), pp.135-154.
14. He, A., Shi, C., Wu, X., Sheng, Y., Zhu, X., Yang, J. and Zhou, Y., 2024. Clusters of Body Fat and Nutritional Parameters are Strongly Associated with Diabetic Kidney Disease in Adults with Type 2 Diabetes. Diabetes Therapy, 15(1), pp.201-214.
15. Goldman, J.D., Busch, R. and Miller, E., 2024. Best Practice Perspectives on Improving Early Detection and Management of Chronic Kidney Disease Associated With Type 2 Diabetes in Primary Care. Clinical Diabetes, p.cd230074.